朗瑪信息(300288.SZ):向特定對象發行股票註冊批覆到期失效
格隆匯9月23日丨朗瑪信息(300288.SZ)公佈,公司於2020年9月28日收到中國證監會出具的《關於同意貴陽朗瑪信息技術股份有限公司向特定對象發行股票註冊的批覆》(證監許可[2020]2329號),同意公司向特定對象發行股票不超過4000萬股,預計募集資金不超過2.83億元,該批覆自同意註冊之日(2020年9月23日)起12個月內有效。
公司取得批覆後,會同中介機構積極推進該次向特定對象發行股票的各項工作。該次募集資金主要用於公司“智慧醫療健康服務平台功能升級及內容擴充項目”,公司於2020年初已用自有資金啟動了該項目,目前該項目按計劃正常推進。
鑑於目前資本市場環境變化並綜合考慮公司經營及資金情況等因素,公司沒有在批覆文件有效期內完成該次向特定對象發行股票事宜,中國證監會關於公司該次向特定對象發行股票的批覆到期自動失效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.